News Sought-after obesity drug Wegovy backed for NHS use Use is restricted to two years in patients enrolled in NHS weight management services.
News Digital alerts ‘improve heart failure drug prescribing’ Doctors were more than twice as likely to prescribe mineralocorticoid drugs after EHR alerts.
News An aura of adult migraine hope as NICE recommends Vyepti Lundbeck’s eptinezumab receives NICE recommendation for the prevention of migraine in adults.
News Lilly slashes insulin price 70%, patient cost cap now $35 Lilly trying to make it easier for patients to access its insulin and help Americans generally.
News Is pharma patient centric? Not according to most doctors Only 45% of healthcare professionals say industry is doing a good job putting patients first.
News More digital mental health therapies backed for NHS use Online CBT programmes could help 40,000 people with depression and anxiety-related conditions.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
